Inactief instrument

Andere talen CorMedix Inc. Nyse

Aandelen

US21900C1009

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

CORMEDIX INC. TO PARTICIPATE IN TWO UPCOMING INVESTOR CONFERENCES	13/05
CorMedix Inc. to Participate in Two Upcoming Investor Conferences	10/05
CorMedix Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	09/05
CorMedix: Q1 Earnings Snapshot	09/05
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update	09/05
Actinium Pharmaceuticals (ATNM) Poised for Breakout as Analysts Project Significant Upside	09/05
CorMedix Inc. To Report First Quarter 2024 Financial Results and Provide a Corporate Update on May 9, 2024	06/05
CORMEDIX INC. ANNOUNCES CMS GRANTS TDAPA TO DEFENCATH	22/04
CorMedix Inc. Announces CMS Grants TDAPA to DefenCath	19/04
CORMEDIX INC. ANNOUNCES U.S. INPATIENT COMMERCIAL AVAILABILITY OF DEFENCATH	16/04
CorMedix's DefenCath Now Commercially Available For US Inpatient Use	15/04
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath® (Taurolidine and Heparin)	15/04
CorMedix Inc. Announces U.S. Inpatient Commercial Availability of DefenCath®? (Taurolidine and Heparin)	15/04
CorMedix Inc. Announces Abstracts at Upcoming Society for Healthcare Epidemiology of America Conference	11/04
Sector Update: Health Care Stocks Decline Late Afternoon	08/04
CorMedix to Supply to DefenCath to Florida-based Dialysis Organization	08/04
CorMedix Inc. Announces Commercial Agreement With ARC Dialysis, LLC	08/04
CorMedix Inc. Announces Commercial Agreement with ARC Dialysis, LLC	08/04
CorMedix Inc. to Present at the Needham Annual Healthcare Conference	27/03
Sector Update: Health Care Stocks Ease Wednesday Afternoon	13/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen CorMedix Inc. Nyse

Aandelen

US21900C1009

Andere talen

Filters